Posts By Alex
-
396Wire StoriesOrBit Markets Achieves SOC 2 Type II Attestation
SINGAPORE–(BUSINESS WIRE)–OrBit Markets, the leading institutional liquidity provider in digital asset options and structured derivatives, announced today that it has successfully achieved...
-
487Wire StoriesMitsubishi Electric Receives Order for Taiwan’s First STATCOM for Power Stabilization
Will help to control and stabilize diversifying power grid and support adoption of renewable energy TOKYO–(BUSINESS WIRE)–Mitsubishi Electric Corporation (TOKYO: 6503) announced...
-
430Wire StoriesMitsubishi Electric and Coherent Enter into A Collaboration to Scale Manufacturing of SiC Power Electronics on A 200 mm Technology Platform
TOKYO & PITTSBURGH–(BUSINESS WIRE)–Mitsubishi Electric Corporation (TOKYO:6503) and Coherent Corp. (NYSE: COHR), a global leader in materials, networking, and lasers, today announced...
-
467Wire Stories
Transforming Fukushima into “Region of Recovery”: Fukushima Prefecture Releases Video of “Fukushima Now,” 12 Years after Great East Japan Earthquake
Transforming Fukushima into “Region of Recovery”: Fukushima Prefecture Releases Video of “Fukushima Now,” 12 Years after Great East Japan Earthquake FUKUSHIMA, Japan–(BUSINESS...
-
440Wire Stories3HOUSE.io Launches Upgraded Platform with New Trending Topics Feed and Portfolio Tracking Tools
SINGAPORE–(BUSINESS WIRE)–3HOUSE.io, the comprehensive platform for Web3 investors, has launched a series of upgrades to its platform, including a new feed of...
-
450Wire StoriesSSR Mining Announces Voting Results From 2023 Annual Meeting of Shareholders
DENVER–(BUSINESS WIRE)–SSR Mining Inc. (NASDAQ/TSX: SSRM, ASX: SSR) (“SSR Mining” or the “Company”) announces that each of the nine nominees listed in...
-
434Wire StoriesBeiGene Presentations at the 2023 ASCO Annual Meeting Reinforce Promise Across Oncology Portfolio
Highlights from early- and late-stage pipeline include — combination data for cornerstone therapies BRUKINSA and tislelizumab — early results for OX40 agonist...
-
567Wire StoriesDaiichi Sankyo Showcases Latest Research Towards Creating New Standards of Care for Patients with Cancer with Data at ASCO and EHA
DESTINY-PanTumor02 late-breaking interim data and DESTINY-CRC02 primary results further support potential of ENHERTU across multiple HER2 expressing cancers TROPION-Lung02 updated results continue...
-
409Wire StoriesTakeda and HUTCHMED Announce New Drug Application (NDA) for Fruquintinib for Treatment of Previously Treated Metastatic Colorectal Cancer Granted Priority Review
− Prescription Drug User Fee Act (PDUFA) Target Action Date Set for November 30, 2023 − NDA Includes Results From the Phase...
-
457Wire StoriesAltium Achieves SOC 2 Type 2, Reinforcing Commitment to Data Security and Compliance
SAN DIEGO–(BUSINESS WIRE)–Altium, LLC (ASX: ALU), the global leader in PCB design software, announces the successful completion of the Service Organization Control...
